Emerging Biotechnology Players: From Innovation to Realization - Market Analysis Report

Datamonitor - Emerging Biotechnology Players: From Innovation to Realization - Market Analysis Report: "Research and analysis highlights
In 2001, the 10 biotechnology industry leaders posted an 18% increase in product revenue, to $10,992m. This was mainly driven by Amgen and Genentech, generating $4,482m and $1,736m, respectively. Therapeutic proteins are likely to maintain the lead, with forecast revenues of $19,053m in 2007. Amgen's Enbrel will be the top biotech blockbuster, with forecast sales of $3,200m in 2007. Second to therapeutic proteins will be antibodies, forecast to generate $7,635m in 2007. Millennium could replace Celltech in the top 10 biotech firms, with forecast product revenue of $710m in 2007. Over the next five years, Millennium, Scios and Isis will be the three leading emerging players in terms of product sales, with forecast combined revenue of $1,369m."

2 comments:

job opportunitya said...

Captivating blog. I love surfing the web for the
type of blogs that you do. It had me on the edge of my
seat and I kept going back to again and again!
Please go over my plastic surgery pic blog.

Anonymous said...

Is this editors space of your blog just a cut-and-paste of others published work or press releases; will you be adding your own analyses?

Blog Archive